$3.03 Billion is the total value of BRAIDWELL LP's 81 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 43.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Sell | ALPHATEC HLDGS INCnote 0.750% 8/0 | $108,210,938 | +4.9% | 101,250,000 | -9.8% | 3.57% | +3.3% | |
| ALGN | Sell | ALIGN TECHNOLOGY INC | $69,210,418 | +49.2% | 207,130 | -5.8% | 2.28% | +46.9% |
| BIIB | Sell | BIOGEN INC | $61,372,898 | -12.2% | 220,742 | -12.6% | 2.02% | -13.7% |
| IRTC | Sell | IRHYTHM TECHNOLOGIES INC | $56,330,581 | +20.8% | 454,169 | -8.7% | 1.86% | +19.0% |
| NTRA | Sell | NATERA INC | $54,534,020 | -16.3% | 982,241 | -39.4% | 1.80% | -17.6% |
| DCPH | Sell | DECIPHERA PHARMACEUTICALS IN | $50,078,873 | -6.6% | 3,241,351 | -0.9% | 1.65% | -8.1% |
| PCVX | Sell | VAXCYTE INC | $49,472,775 | -24.3% | 1,319,978 | -3.1% | 1.63% | -25.4% |
| KIDS | Sell | ORTHOPEDIATRICS CORP | $44,239,997 | +6.6% | 998,871 | -4.4% | 1.46% | +4.9% |
| Sell | INSMED INCnote 1.750% 1/1 | $36,486,219 | -3.1% | 39,963,000 | -90.0% | 1.20% | -4.7% | |
| CRNX | Sell | CRINETICS PHARMACEUTICALS IN | $32,436,607 | -48.9% | 2,019,714 | -41.8% | 1.07% | -49.7% |
| Sell | NEOGENOMICS INCnote 1.250% 5/0 | $30,958,125 | -15.1% | 33,000,000 | -23.3% | 1.02% | -16.4% | |
| PEN | Sell | PENUMBRA INC | $29,832,092 | -17.6% | 107,044 | -34.3% | 0.98% | -18.9% |
| LEGN | Sell | LEGEND BIOTECH CORPsponsored ads | $29,018,844 | -11.7% | 601,801 | -8.6% | 0.96% | -13.1% |
| Sell | TRAVERE THERAPEUTICS INCnote 2.250% 3/0 | $27,868,050 | -2.8% | 28,350,000 | -9.6% | 0.92% | -4.4% | |
| KRYS | Sell | KRYSTAL BIOTECH INC | $27,863,762 | -1.8% | 348,036 | -2.8% | 0.92% | -3.4% |
| MRUS | Sell | MERUS N V | $27,104,746 | -12.3% | 1,473,084 | -26.3% | 0.89% | -13.7% |
| SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $19,431,435 | -38.6% | 920,049 | -26.0% | 0.64% | -39.5% |
| GMED | Sell | GLOBUS MED INCcl a | $18,985,728 | -25.6% | 335,200 | -2.5% | 0.63% | -26.8% |
| Sell | INVITAE CORPnote 2.000% 9/0 | $14,842,012 | -12.9% | 16,781,000 | -21.9% | 0.49% | -14.2% | |
| LUNG | Sell | PULMONX CORP | $13,005,627 | -4.9% | 1,163,294 | -28.3% | 0.43% | -6.3% |
| ARGX | Sell | ARGENX SEsponsored adr | $9,165,468 | -50.8% | 24,600 | -50.0% | 0.30% | -51.7% |
| TMDX | Sell | TRANSMEDICS GROUP INC | $7,456,300 | -60.2% | 98,459 | -67.5% | 0.25% | -60.8% |
| Sell | INSMED INCnote 0.750% 6/0 | $2,721,080 | -67.2% | 3,500,000 | -65.0% | 0.09% | -67.6% | |
| SILK | Sell | SILK RD MED INC | $2,478,142 | -88.8% | 63,331 | -84.8% | 0.08% | -88.9% |
| IMTX | Sell | IMMATICS N.V | $2,223,780 | -79.6% | 322,287 | -74.2% | 0.07% | -80.0% |
| ESPR | Sell | ESPERION THERAPEUTICS INC NE | $1,926,315 | -90.9% | 1,211,519 | -64.3% | 0.06% | -91.0% |
| REPL | Sell | REPLIMUNE GROUP INC | $1,300,924 | -92.8% | 73,665 | -88.9% | 0.04% | -92.9% |
| ITOS | Exit | ITEOS THERAPEUTICS INC | $0 | – | -71,585 | -100.0% | -0.05% | – |
| NKTR | Exit | NEKTAR THERAPEUTICS | $0 | – | -620,280 | -100.0% | -0.05% | – |
| Exit | MOONLAKE IMMUNOTHERAPEUTICSclass a ord | $0 | – | -381,120 | -100.0% | -0.13% | – | |
| MIST | Exit | MILESTONE PHARMACEUTICALS IN | $0 | – | -1,164,849 | -100.0% | -0.16% | – |
| FUSN | Exit | FUSION PHARMACEUTICALS INC | $0 | – | -2,000,000 | -100.0% | -0.21% | – |
| KOD | Exit | KODIAK SCIENCES INC | $0 | – | -914,209 | -100.0% | -0.22% | – |
| ALLK | Exit | ALLAKOS INC | $0 | – | -920,304 | -100.0% | -0.26% | – |
| NKTX | Exit | NKARTA INC | $0 | – | -1,525,800 | -100.0% | -0.31% | – |
| VRDN | Exit | VIRIDIAN THERAPEUTICS INC | $0 | – | -313,403 | -100.0% | -0.31% | – |
| Exit | BIOMARIN PHARMACEUTICAL INCnote 0.599% 8/0 | $0 | – | -9,000,000 | -100.0% | -0.32% | – | |
| PTGX | Exit | PROTAGONIST THERAPEUTICS INC | $0 | – | -927,800 | -100.0% | -0.34% | – |
| COO | Exit | COOPER COS INC | $0 | – | -52,115 | -100.0% | -0.58% | – |
| IMGN | Exit | IMMUNOGEN INC | $0 | – | -3,474,497 | -100.0% | -0.58% | – |
| EW | Exit | EDWARDS LIFESCIENCES CORP | $0 | – | -235,319 | -100.0% | -0.59% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -140,352 | -100.0% | -0.61% | – |
| RAPT | Exit | RAPT THERAPEUTICS INC | $0 | – | -1,000,000 | -100.0% | -0.66% | – |
| APLS | Exit | APELLIS PHARMACEUTICALS INC | $0 | – | -389,596 | -100.0% | -0.68% | – |
| Exit | BIOMARIN PHARMACEUTICAL INCnote 1.250% 5/1 | $0 | – | -19,200,000 | -100.0% | -0.70% | – | |
| ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -1,493,121 | -100.0% | -0.80% | – |
| Exit | QUIDELORTHO CORP | $0 | – | -300,437 | -100.0% | -0.86% | – | |
| TVTX | Exit | TRAVERE THERAPEUTICS INC | $0 | – | -1,455,585 | -100.0% | -1.03% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GUARDANT HEALTH INC | 4 | Q3 2023 | 6.3% |
| EXACT SCIENCES CORP | 4 | Q3 2023 | 4.4% |
| NOVOCURE LTD | 4 | Q3 2023 | 3.9% |
| NANOSTRING TECHNOLOGIES INC | 4 | Q3 2023 | 4.0% |
| NEVRO CORP | 4 | Q3 2023 | 3.4% |
| BRIDGEBIO PHARMA INC | 4 | Q3 2023 | 3.5% |
| ALPHATEC HLDGS INC | 4 | Q3 2023 | 3.6% |
| GLAUKOS CORP | 4 | Q3 2023 | 3.0% |
| VAXCYTE INC | 4 | Q3 2023 | 2.8% |
| XENON PHARMACEUTICALS INC | 4 | Q3 2023 | 2.5% |
View BRAIDWELL LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G | 2023-02-14 |
| SC 13G | 2023-02-14 |
| SC 13G | 2023-02-14 |
View BRAIDWELL LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.